Rilpivirine (Edurant): A New NNRTI

Note: This is an archived resource. It is provided here for general reference, but users are advised to refer to other sources to confirm information. See full site Disclaimer.

22 slides covering the data behind the recent FDA approval of the new NNRTI, Rilpivirine (Edurant), and in particular, how it compares to Efavirenz.

Check all that apply
Check all that apply

Browse more

Add comment

Log in to post comments